Automotive Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.

Press releases published on July 2, 2026

Jul. 2, 2026

Capstone Infrastructure Corporation Provides Notice of Dividend Rates on Cumulative 5-Year Rate Reset Preferred Shares, Series A and Cumulative Floating Rate Preferred Shares, Series B

Indeterminate GlobeNewswire

Jul. 2, 2026

Fortis Inc. to Hold Teleconference and Webcast on July 31 to Discuss Second Quarter 2026 Results

Indeterminate GlobeNewswire

Jul. 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Capital Power to release second quarter 2026 results on July 29

Indeterminate GlobeNewswire

Jul. 2, 2026

Range Announces Conference Call to Discuss Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 2, 2026

Latin Metals Reports AGM Results

Indeterminate GlobeNewswire

Jul. 2, 2026

A' Heavy Machinery Design Awards 2026 Call for Entries Announced

Indeterminate EIN Presswire

Jul. 2, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jul. 2, 2026

Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire

Jul. 2, 2026

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire